Shashi Shekhar M.

Investor and Advisor | Angel investing, fund raising, investment banking

📍 India🔄 Updated September 2026💼 4 investments📅 4 years investing🗓 Last invested Feb 2024
Angel investor🌍 India
4
Total investments
0
Early stage
3
Mid stage
0
Late stage
4y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Feb 2024
Supply Chain Financing Fintech solving for the need of Deep Tier discounting. We enable deep tier vendors (L2, L3) who are indirect suppliers to OEMs/ Mid Corporates with access to quick and affordable credit with our SCF solution. Solution is built on enterprise blockchain thereby ensuring deep tier discounting along with scalability & immutability of the data. Core Team comprises of experienced banking and tech professional with years of experience in solving existing problem statement.
Investor and Advisor
Jan 2023
Genefitletics, a biotech company founded in 2019, uses system biology & mathematics to accelerate the speed at which application of scientific discoveries & molecular data driven personalization empowers people to reclaim control of their health Harnessing the power of next generation sequencing, cloud computing & machine learning, Genefitleticss system biology platform measures & analyzes biology & chemistry of an individual at molecular level to deeply understand origin & progression of chronic diseases in order to prevent, diagnose them early, stop their progression and reverse them. This data driven platform that precisely characterize human-microbial interactions : 1)Provide patients with unique molecular insights & precision nutrition interventions to bring their body back into homeostasis 2)Give healthcare practitioners access to hard to detect pre disease signals which conventional clinical diagnostic tests cannot identify, enabling them to align their interventions with patient’s unique biochemical individuality The company is led by a team of researchers, inventors, industry experts & passionate & curious entrepreneurs with a combined leadership & executive experience of 30 + years who are on a journey to impact human health. The company has been awarded as : 1) Best chronic illness prevention R &D Biotech company 2024-South Asia by Global Health & Pharma 2)Biotech Innovation Excellence Award 2024- by Global Heath & Pharma 3)Microbiome Therapeutics as a service platform, 2023 by AWS & MINFY in association with CNBC 4)Chronic Illness Prevention R&D Biotech Company- Asia,2022 by Global Health Pharma 5)Specialist Biotech Company of the year, CorporateLiveWire, Global Awards, 2022/23 6) Microbiome Therapeutics as a service platform, 2023 by Global Health & Pharma 7) Chronic Illness Prevention R&D Biotech Company of the Year 2023 - Asia by AI Global Media
Investor
Jul 2022
Bioheaven360 Genotec P Ltd is a technology innovator and product manufacturer dedicated to personalized medicine and healthy aging theranostics that keep people thriving longer. By combining cognitive AI with multimodal biological markers, we stratify chronic illness risk during the silent phase and empower preventive strategies with individualized insights and stem cell driven therapeutics. Our approach includes predictive intelligence, proactive care pathways, and personalised therapeutics designed to extend healthy life years. We have built an intelligent health platform that predicts risks early and helps individuals prepare for and manage chronic conditions effectively. We are working to develop ANGD an AIML-NLP-Genomics-Driven early warning systems capable of identifying high-risk individuals in asymtomatic phase using deep phenotyping. Moving diseasewise and organwise we have developed models for Osteoporosis and now moving to add Liver Cirrhosis complications and other chronic diseases. Our solution revolutionizes chronic illness management by providing early, data-driven assessments that identify potential health risks before traditional symptoms appear. Using advanced predictive analytics and continuous health monitoring, we empower patients and healthcare providers to take proactive steps—reducing hospitalizations, improving quality of life, and lowering long-term care costs. Through ABHA integration, we align with the goals of NDHM and Atmanirbhar Bharat. By shifting focus from reactive treatment to anticipatory prevention, we aim to transform chronic disease care into a more efficient, personalized, and sustainable model and achieve longevity & healthy aging. We are working diligently to also develop biological therapeutics to provide personalised intervention as a solution towards remaining healthy and achieve longer life. Bioheaven is "Turning Human Needs into Careful Solutions"​..........
Investor
May 2022
Deciwood is the Indian manufacturer of wooden made Bluetooth speakers. We are committed to providing excellent quality portable audio devices in classic-retro designs. Hence, you get to experience both high-quality music and old-school charm. And our in-house tech Energy Tube is there to disrupt audio space in India.
Experience · 5 entries
All (5)
Investments (4)
2024
Investor
Feb 2024
Supply Chain Financing Fintech solving for the need of Deep Tier discounting. We enable deep tier vendors (L2, L3) who are indirect suppliers to OEMs/ Mid Corporates with access to quick and affordable credit with our SCF solution. Solution is built on enterprise blockchain thereby ensuring deep tier discounting along with scalability & immutability of the data. Core Team comprises of experienced banking and tech professional with years of experience in solving existing problem statement.
2023
Investor and Advisor
Jan 2023
Genefitletics, a biotech company founded in 2019, uses system biology & mathematics to accelerate the speed at which application of scientific discoveries & molecular data driven personalization empowers people to reclaim control of their health Harnessing the power of next generation sequencing, cloud computing & machine learning, Genefitleticss system biology platform measures & analyzes biology & chemistry of an individual at molecular level to deeply understand origin & progression of chronic diseases in order to prevent, diagnose them early, stop their progression and reverse them. This data driven platform that precisely characterize human-microbial interactions : 1)Provide patients with unique molecular insights & precision nutrition interventions to bring their body back into homeostasis 2)Give healthcare practitioners access to hard to detect pre disease signals which conventional clinical diagnostic tests cannot identify, enabling them to align their interventions with patient’s unique biochemical individuality The company is led by a team of researchers, inventors, industry experts & passionate & curious entrepreneurs with a combined leadership & executive experience of 30 + years who are on a journey to impact human health. The company has been awarded as : 1) Best chronic illness prevention R &D Biotech company 2024-South Asia by Global Health & Pharma 2)Biotech Innovation Excellence Award 2024- by Global Heath & Pharma 3)Microbiome Therapeutics as a service platform, 2023 by AWS & MINFY in association with CNBC 4)Chronic Illness Prevention R&D Biotech Company- Asia,2022 by Global Health Pharma 5)Specialist Biotech Company of the year, CorporateLiveWire, Global Awards, 2022/23 6) Microbiome Therapeutics as a service platform, 2023 by Global Health & Pharma 7) Chronic Illness Prevention R&D Biotech Company of the Year 2023 - Asia by AI Global Media
2022
Investor
Jul 2022
Bioheaven360 Genotec P Ltd is a technology innovator and product manufacturer dedicated to personalized medicine and healthy aging theranostics that keep people thriving longer. By combining cognitive AI with multimodal biological markers, we stratify chronic illness risk during the silent phase and empower preventive strategies with individualized insights and stem cell driven therapeutics. Our approach includes predictive intelligence, proactive care pathways, and personalised therapeutics designed to extend healthy life years. We have built an intelligent health platform that predicts risks early and helps individuals prepare for and manage chronic conditions effectively. We are working to develop ANGD an AIML-NLP-Genomics-Driven early warning systems capable of identifying high-risk individuals in asymtomatic phase using deep phenotyping. Moving diseasewise and organwise we have developed models for Osteoporosis and now moving to add Liver Cirrhosis complications and other chronic diseases. Our solution revolutionizes chronic illness management by providing early, data-driven assessments that identify potential health risks before traditional symptoms appear. Using advanced predictive analytics and continuous health monitoring, we empower patients and healthcare providers to take proactive steps—reducing hospitalizations, improving quality of life, and lowering long-term care costs. Through ABHA integration, we align with the goals of NDHM and Atmanirbhar Bharat. By shifting focus from reactive treatment to anticipatory prevention, we aim to transform chronic disease care into a more efficient, personalized, and sustainable model and achieve longevity & healthy aging. We are working diligently to also develop biological therapeutics to provide personalised intervention as a solution towards remaining healthy and achieve longer life. Bioheaven is "Turning Human Needs into Careful Solutions"​..........
Investor
May 2022
Deciwood is the Indian manufacturer of wooden made Bluetooth speakers. We are committed to providing excellent quality portable audio devices in classic-retro designs. Hence, you get to experience both high-quality music and old-school charm. And our in-house tech Energy Tube is there to disrupt audio space in India.
2007
Associate Director
2007
We are a leading international banking group, with a presence in 54 of the world’s most dynamic markets. Our purpose is to drive commerce and prosperity through our unique diversity, and our heritage and values are expressed in our brand promise, here for good. If you’re interested joining Standard Chartered sign up to our Talent Network. Link: https://www.sc.com/careers/talentnetwork Standard Chartered PLC is listed on the London and Hong Kong stock exchanges.
Investment activity
2022–2024 · 4 investments
202222023120241
Recent (last 2 years)Earlier